Strategy Asset Managers’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Strategy Asset Managers’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-3,076	Closed	-$471K	–	276
2024 Q2	$471K	Buy	+3,076	New	+$462K	0.1%	138
2023 Q4	–	Sell	-3,152	Closed	-$461K	–	233
2023 Q3	$461K	Buy	3,152 +76	+2%	+$11.6K	0.12%	131
2023 Q2	$471K	Buy	+3,076	New	+$480K	0.1%	138

Other funds holding FBT

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

BFG

Berger Financial Group Plymouth, Minnesota $1.79B AUM 15.72% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Strategy Asset Managers's FBT Position: Q3 2024 in Review

Strategy Asset Managers sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q3 2024, closing a stake of 3,076 shares — an estimated $471K sold.

Strategy Asset Managers first reported a position in FBT in Q2 2023 and held it in 3 quarters. The position peaked at $471K in Q2 2024. 257 funds tracked by Wall St. Rank hold FBT as of Q3 2024.

Strategy Asset Managers reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q3 2024 after selling out during the quarter.
Strategy Asset Managers sold 3,076 First Trust NYSE Arca Biotechnology Index Fund shares in Q3 2024, an estimated $471K.
Strategy Asset Managers first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q2 2023 and held it in 3 quarters.
Strategy Asset Managers's First Trust NYSE Arca Biotechnology Index Fund position peaked at $471K in Q2 2024.
257 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q3 2024.

Based on Strategy Asset Managers's 13F filing for Q3 2024, filed 8 Nov 2024.